Clinical and Radiographic Evaluation of Pulpotomies in Primary Molars Using Tricalcium Silicate Cements

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-12

Study Completion Date

2024-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to evaluate the success rate of pulpotomies in temporary molars using different types of hemostats and pulp coating materials based on tricalcium silicates, in patients who have attended the Dental Clinic of the International University of Catalonia (UIC).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MEDCEM PC and MTA in Pulpotomies of Primary Molars

NCT02291120

Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.

UNKNOWN PHASE4

MTA and Biodentine in Pulpotomized Primary Molars

NCT01591278

Primary Molar Pulpotomy

UNKNOWN PHASE4

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

NCT05102318

Pulp Disease, Dental

UNKNOWN NA

Tomographic Evaluation of Pulpotomy in Young Permanent Teeth Using Human-treated Dentin Matrix

NCT06116695

Pulpotomy of Young Permanent Molars

COMPLETED PHASE1/PHASE2

PRF Pulpotomy Using Different Bioceramic Materials in Permanent Molars

NCT04784949

Irreversible Pulpitis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective randomized clinical trial study has been approved by the

Scientific Committee in January of 2017 and by Ethics Committee (END-ECL- 2017-01) . It will be conducted in patients needing a vital pulp

therapy treatment at the Pediatric Dentistry Department of Universitat Internacional de Catalunya (Sant Cugat del Vallés, Barcelona, Spain). The necessary statistical sample size assuming an alpha risk of 0.05, a beta risk of 0.05 and a power of 95% sample, the required sample obtained by group resulted in 52. Given an estimate upwards of 20% of drop-outs in controls, the final size results in 62.4 (63 cases per group).

The data collection will be recollected using Excel program. Statgraphics Centurion XV software (StatPoint Technologies, Inc., Warrenton, VA, USA) will be used for statistical analysis. The chi-square test will be used and logistic regression analysis of the results will be performed to assess differences between groups with a significance level of P \<0.05.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Molar Pulpotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pulp Dressing MTA Angelus

pulp therapy

Group Type EXPERIMENTAL

MTA HP Repair

Intervention Type OTHER

pulp therapy

Pulp Dressing MTA Pro Root

pulp therapy

Group Type EXPERIMENTAL

MTA Pro Root

Intervention Type OTHER

pulp therapy

Pulp Dressing Biodentine

pulp therapy

Group Type EXPERIMENTAL

Biodentine

Intervention Type OTHER

pulp therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MTA Pro Root

pulp therapy

Intervention Type OTHER

MTA HP Repair

pulp therapy

Intervention Type OTHER

Biodentine

pulp therapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Responsible patients or parents or guardians who demonstrate that they understand the study and are willing to participate, as evidenced by signing the voluntary informed consent and receiving a signed and dated copy of the informed consent form.
* Children under 18 years of age with informed parental consent, correctly understood.
* Patient understands and is willing to comply with all study procedures and restrictions.
* Absence of clinical and radiographic evidence of pulp degeneration such as excessive bleeding, internal and / or external root resorption, destruction of the furcation.
* Asymptomatic and vital primary molars whose pulp exposure occurred during caries removal.

Exclusion Criteria

* Patients with systemic pathologies (diabetes, inmunosuppresed or any clinically significant or relevant oral abnormality).
* Previous history of allergic reaction to local anesthesics or to the different constituents of the pulp agents to be studied.
* Pulp diagnosis of irreversible pulpits or pulp necrosis, root resorption, root fractures, pathological mobility, spontaneous pain, impossibility of restoration, and if pulpotomy is not the treatment of choice.

Minimum Eligible Age

4 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes